ArticleNature medicine2019

Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome.

Ergin Beyret et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.